Www.aodhealth.org1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.

Slides:



Advertisements
Similar presentations
CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence April 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
Journal Club Alcohol and Health: Current Evidence January-February 2006.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2009.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2012.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Which factors predict outcome in the nonoperative treatment of patellofemoral pain syndrome? A prospective follow-up study Kannus P, Nittymaki S. Med.
Prognosis study EBM questions. Prognostic factors Characteristics of patient that may predict eventual outcome Several types: demographic (eg age) disease-specific.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
CAT 4: How to Read a Prognosis Article Maribeth Chitkara, MD Rachel Boykan, MD.
EBM --- Journal Reading Presenter :黃美琴 Date : 2005/10/27.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence March–April 2017
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence July-August, 2018
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007

Featured Article A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years De Gottardi A, et al. Arch Intern Med. 2007;167(11): 1183–1188.

Study Objective To identify risk factors for alcohol use after liver transplantation (LT) for alcoholic liver disease

Study Design 387 patients who underwent LT for alcoholic liver disease were retrospectively enrolled in this study. Pre-LT alcohol use was assessed with the High-Risk Alcoholism Relapse (HRAR) scale. –The HRAR assesses chronicity of heavy drinking, prior alcohol consumption, and prior alcohol treatment history. Post-LT alcohol use was assessed at regular intervals over an average of 61 months. –Harmful use was defined as about >3.5 drinks of alcohol per day plus alcohol-related physical or mental consequences.

Assessing Validity of an Article about Prognosis Are the results valid? What are the results? How can I apply the results to patient care?

Are the Results Valid? Was the sample representative? Were the subjects sufficiently homogeneous with respect to prognostic risk? Was follow-up sufficiently complete? Were objective and unbiased outcome criteria used?

Was the sample representative? Patients included all those who received LT in 2 European hospitals between 1989 and 2005 (n=387). Indication for LT was based on... –the presence of end-stage liver disease, in which LT was the only option for survival; –the absence of medical or surgical contraindications, and –a period of abstinence (a minimum of 3 months was considered necessary).

Were the subjects sufficiently homogeneous with respect to prognostic risk?  High-Risk Alcoholism Relapse (HRAR) scores:  0–3 in 356 (93%) of subjects  4–6 in 27 (7%) of subjects

Was follow-up sufficiently complete?  Average follow-up after LT was 61 months (range of 0–192 months).

Were objective and unbiased outcome criteria used? Alcohol relapse was determined by self-report and thus could have been under-reported. Uniform criteria were used to define the outcome of relapse. No information about adherence to post LT follow- up visits was provided, raising a concern about selective reporting.

What are the Results? How likely are the outcomes over time? How precise are the estimates of likelihood?

How likely are the outcomes over time? Results: During an average follow-up of 61 months after LT, 12% had harmful alcohol use. In adjusted analyses, the following were significantly associated with harmful alcohol use after LT: –a score of >3 on the HRAR scale (odds ratio [OR], 10.7) –psychiatric comorbidity (OR, 7.8) –pre-LT abstinence from alcohol for ≤6 months (OR, 3.3)

How likely are the outcomes over time? (cont.) Harmful alcohol use after LT occurred in… –5% of patients with none of the above factors, –18% with 1 factor, –64% with 2 factors, and –100% with all 3 factors.

How precise are the estimates of likelihood? The 95% Confidence Intervals (CIs) are wide: –For a score of >3 on the HRAR scale: OR, 10.7; 95% CI, 3.8–30.0 –For psychiatric comorbidity: OR, 7.8; 95% CI, 3.1–20.0 –For pre-LT abstinence from alcohol for <6 months: OR, 3.3; 95% CI, 1.2–9.3

How Can I Apply the Results to Patient Care? Were the study patients and their management similar to those in my practice? Was the follow-up sufficiently long? Can I use the results in the management of patients in my practice?

Were the study patients similar to those in my practice? 76% were male. Average age at transplantation was 51 years. 57% were “blue collar” workers. 21% had an anxiety or depressive disorder. 93% had low scores (0–3) on the HRAR scale.

Was the follow-up sufficiently long? Average follow-up after LT was 61 months.

Can I use the results in the management of patients in my practice? This observational study provides data indicating that LT patients are more likely to relapse if they have the following: –more chronic heavy drinking –greater daily alcohol consumption –extensive prior treatment histories –psychiatric comorbidity –shorter durations of abstinence Knowledge of these factors can help predict the likelihood of relapse to harmful drinking.